Nicotinamide derivatives as selective inhibitors of PDE4

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.9, Iss.4, 1999-04, pp. : 481-485

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PDE4 inhibitors 1998

By Norman P.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 771-784

Informa Healthcare

Access to resources Recommend Favorite

PDE4 inhibitors 1999

By Norman P.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 8, 1999-08 ,pp. : 1101-1118

Informa Healthcare

Access to resources Recommend Favorite

Dialkoxypyridylalkylimidazolidine PDE4B inhibitors

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 3, 2000-03 ,pp. : 357-359

Informa Healthcare

Access to resources Recommend Favorite

The therapeutic potential of PDE4 inhibitors

By Dyke H.J. Montana J.G.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 9, 1999-09 ,pp. : 1327-1327

Informa Healthcare

Access to resources Recommend Favorite

Selective Phosphodiesterase (PDE)-4 Inhibitors: A Novel Approach to Treating Memory Deficit?

By Ghavami Afshin

Drugs in R&D, Vol. 7, Iss. 2, 2006-01 ,pp. : 63-71

Adis International

Access to resources Recommend Favorite